RGAGX | VILSX | RGAGX / VILSX | |
Total Expense Ratio | 0.30 | 0.89 | 34% |
Annual Report Gross Expense Ratio | 0.30 | 1.03 | 29% |
Fund Existence | 16 years | 5 years | - |
Gain YTD | 18.256 | 0.285 | 6,410% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 336B | 391M | 85,934% |
Annual Yield % from dividends | 0.58 | 0.33 | 174% |
Returns for 1 year | 12.02 | -13.29 | -90% |
Returns for 3 years | 73.65 | 15.22 | 484% |
Returns for 5 years | 41.92 | -23.27 | -180% |
Returns for 10 years | 103.73 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
GMVAX | 16.47 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
CLBFX | 38.87 | 0.04 | +0.10% |
American Funds American Balanced 529F | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst | |||
TAISX | 13.83 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq I |